Reframing recalcitrance for small-cell lung cancer

被引:361
作者
Blackhall, F. H. [1 ]
机构
[1] Christie Hosp NHS Trust Med Oncol, Manchester, Lancs, England
关键词
CONVERT;
D O I
10.1016/j.annonc.2021.03.207
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:829 / 830
页数:2
相关论文
共 19 条
[1]   Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse [J].
Almodovar, Karinna ;
Iams, Wade T. ;
Meador, Catherine B. ;
Zhao, Zhiguo ;
York, Sally ;
Horn, Leora ;
Yan, Yingjun ;
Hernandez, Jennifer ;
Chen, Heidi ;
Shyr, Yu ;
Lim, Lee P. ;
Raymond, Christopher K. ;
Lovly, Christine M. .
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (01) :112-123
[2]  
[Anonymous], 2014, CANC INCIDENCE 5 CON
[3]  
[Anonymous], 2020, BRIST MYERS SQUIBB S
[4]  
[Anonymous], 2021, MERCK PROV UPD KEYTR
[5]   Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study [J].
Blackhall, Fiona ;
Jao, Kevin ;
Greillier, Laurent ;
Cho, Byoung Chul ;
Penkov, Konstantin ;
Reguart, Noemi ;
Majem, Margarita ;
Nackaerts, Kristiaan ;
Syrigos, Konstantinos ;
Hansen, Karin ;
Schuette, Wolfgang ;
Cetnar, Jeremy ;
Cappuzzo, Federico ;
Okamoto, Isamu ;
Erman, Mustafa ;
Langer, Seppo W. ;
Kato, Terufumi ;
Groen, Harry ;
Sun, Zhaowen ;
Luo, Yan ;
Tanwani, Poonam ;
Caffrey, Laura ;
Komarnitsky, Philip ;
Reinmuth, Niels .
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (09) :1547-1558
[6]   Reframing recalcitrance for small-cell lung cancer [J].
Blackhall, F. H. .
ANNALS OF ONCOLOGY, 2021, 32 (07) :829-830
[7]   Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial [J].
Faivre-Finn, Corinne ;
Snee, Michael ;
Ashcroft, Linda ;
Appel, Wiebke ;
Barlesi, Fabrice ;
Bhatnagar, Adityanarayan ;
Bezjak, Andrea ;
Cardenal, Felipe ;
Fournel, Pierre ;
Harden, Susan ;
Le Pechoux, Cecile ;
McMenemin, Rhona ;
Mohammed, Nazia ;
O'Brien, Mary ;
Pantarotto, Jason ;
Surmont, Veerle ;
Van Meerbeeck, Jan P. ;
Woll, Penella J. ;
Lorigan, Paul ;
Blackhall, Fiona .
LANCET ONCOLOGY, 2017, 18 (08) :1116-1125
[8]   Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities [J].
Gay, Carl M. ;
Stewart, C. Allison ;
Park, Elizabeth M. ;
Diao, Lixia ;
Groves, Sarah M. ;
Heeke, Simon ;
Nabet, Barzin Y. ;
Fujimoto, Junya ;
Solis, Luisa M. ;
Lu, Wei ;
Xi, Yuanxin ;
Cardnell, Robert J. ;
Wang, Qi ;
Fabbri, Giulia ;
Cargill, Kasey R. ;
Vokes, Natalie, I ;
Ramkumar, Kavya ;
Zhang, Bingnan ;
Della Corte, Carminia M. ;
Robson, Paul ;
Swisher, Stephen G. ;
Roth, Jack A. ;
Glisson, Bonnie S. ;
Shames, David S. ;
Wistuba, Ignacio I. ;
Wang, Jing ;
Quaranta, Vito ;
Minna, John ;
Heymach, John, V ;
Byers, Lauren Averett .
CANCER CELL, 2021, 39 (03) :346-+
[9]   First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer [J].
Horn, L. ;
Mansfield, A. S. ;
Szczesna, A. ;
Havel, L. ;
Krzakowski, M. ;
Hochmair, M. J. ;
Huemer, F. ;
Losonczy, G. ;
Johnson, M. L. ;
Nishio, M. ;
Reck, M. ;
Mok, T. ;
Lam, S. ;
Shames, D. S. ;
Liu, J. ;
Ding, B. ;
Lopez-Chavez, A. ;
Kabbinavar, F. ;
Lin, W. ;
Sandler, A. ;
Liu, S. V. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (23) :2220-2229
[10]   Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey [J].
Levy, Antonin ;
Hendriks, Lizza E. L. ;
Le Pechoux, Cecile ;
Falk, Sally ;
Besse, Benjamin ;
Novello, Silvia ;
Dingemans, Anne-Marie C. ;
Hasan, Baktiar ;
Reck, Martin ;
Berghmans, Thierry ;
Faivre-Finn, Corinne .
LUNG CANCER, 2019, 136 :145-147